Artwork

Content provided by Clarivate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clarivate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The evolution of the asset-centric approach in biotech venture capital

47:29
 
Share
 

Manage episode 294730125 series 2813433
Content provided by Clarivate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clarivate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Francesco De Rubertis, a co-founder and managing partner at Medicxi, one of the most prominent financial supporters of innovative biotech activity. Francesco provides insights into how the biotech venture capital model has evolved in the past decades to an asset-centric approach, and discusses Centessa, which recently secured $250m in funding. Learn more in the full episode.

Hosted on Acast. See acast.com/privacy for more information.

  continue reading

48 episodes

Artwork
iconShare
 
Manage episode 294730125 series 2813433
Content provided by Clarivate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clarivate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Francesco De Rubertis, a co-founder and managing partner at Medicxi, one of the most prominent financial supporters of innovative biotech activity. Francesco provides insights into how the biotech venture capital model has evolved in the past decades to an asset-centric approach, and discusses Centessa, which recently secured $250m in funding. Learn more in the full episode.

Hosted on Acast. See acast.com/privacy for more information.

  continue reading

48 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide